Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial

Primary graft dysfunction (PGD) and non-function (PNF) happen in 8.7-24.7% and 0.9-7.2% of liver transplant recipients, respectively. These phenomena increase treatment cost and patients’ death. This study assessed the effect of L-carnitine supplementation on the incidences of PNF/PGD in liver trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Khajeh, Behrouz, Dashti-Khavidaki, Simin, Nasiri-Toosi, Mohsen, Mohammadi, Keyhan, Jafari, Atefeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937745/
https://www.ncbi.nlm.nih.gov/pubmed/32038730
http://dx.doi.org/10.4103/1735-5362.272537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937745/
https://www.ncbi.nlm.nih.gov/pubmed/32038730
http://dx.doi.org/10.4103/1735-5362.272537

Ejemplares similares